Journal
EYE
Volume 20, Issue 4, Pages 417-422Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.eye.6701877
Keywords
cataract; hormone replacement therapy; case-control
Categories
Funding
- Medical Research Council [G108/492] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- MRC [G108/492] Funding Source: UKRI
- Medical Research Council [G108/492] Funding Source: researchfish
Ask authors/readers for more resources
Purpose Laboratory studies have suggested that hormone replacement therapy (HRT) may protect against the development of cataract, but epidemiological studies in humans have thus far been inconclusive. The aim of this study was to assess the association between hormone replacement therapy and cataract. Methods Population-based case-control study using data from the General Practice Research Database in the UK. Participants were 10 000 women aged 45 years and over with diagnosed cataract and 10 000 controls matched on age, general practice, and calendar period. Results The crude odds ratio for the association between cataract and ever-use of oestrogen-only hormone replacement therapy was 1.13 (95% CI 0.99-1.29). This reduced to 0.81 (95% CI 0.71-0.94) after adjustment for consultation rate. Similarly, the crude odds ratio for the association between cataract and ever-use of a formulation containing oestrogen and progestogen was 1.18 ( 95% CI 1.01-1.39), reducing to 0.86 ( 95% CI 0.72-1.02) after adjustment for consultation rate. Conclusions Oestrogen-only and oestrogen progestogen hormone replacement therapies are associated with a small reduced risk of cataract. This data adds to the growing body of evidence on the effects of HRT on health. All potential benefits and risks of this therapy should be taken into account when considering its use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available